Along the same line, a recent paper using a proteomic strategy identified another protein, Protein Tyrosine Phosphatase Receptor Type G (PTPRG), to be involved in controlling FGFR1 activity and influences sensitivity of sarcoma cells to FGFR kinase inhibitors [47]. Here, FGFR1 is linked to sarcoma.